FDA approves Steglatro for Type II diabetes

FDA approved Steglatro ertugliflozin from Merck & Co. Inc. (NYSE:MRK) and Pfizer Inc. (NYSE:PFE) as an adjunct to diet and

Read the full 202 word article

User Sign In